Navigation Links
Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
Date:7/8/2010

cesses are regulated will help to develop more effective anticancer therapeutics.

Costas A. Lyssiotis, PhD, with his sponsor Lewis C. Cantley, PhD, at Beth Israel Deaconess Medical Center, Boston, Massachusetts, is studying the underlying differences in cellular metabolism between cancer cells and normal cells. In particular, he is interested in understanding (i) how cancer cells rewire their metabolic networks to satisfy the demands of continuous proliferation and (ii) what happens to cancerous cells when they are forced to behave metabolically like normal cells. While his initial studies will be aimed at addressing these questions in breast cancer, these studies have the potential to provide new ways to treat many types of cancers.

Dale Muzzey, PhD [HHMI Fellow] with his sponsor Jonathan S. Weissman, PhD, at the University of California, San Francisco, California, is studying how both the sequence and structure of mRNAs affect the efficiency by which they are translated into protein in the yeast Candida albicans. Defects in mRNA translation have been linked to several cancers, and he hopes to reveal features of translational control that generalize to humans. Additionally, his project may highlight potential ways to combat Candida infections, which frequently afflict immune-compromised cancer patients undergoing therapy.

Jason A. Reuter, PhD, with his sponsor Michael P. Snyder, PhD, at Stanford University, Stanford, California, is investigating the role of a new class of RNAs (long non-protein-coding RNAs) in regulation of cellular differentiation, a process that generates the specialized cell types found throughout our bodies. Aberrant differentiation is commonly observed in human tumors; poorly differentiated tumor cells are associated with the worst prognosis. Research on the regulation of normal cellular differentiation may, therefore, provide insight into the mechanisms underlying tumor progression. These RNAs may also represe
'/>"/>

Contact: Yung S. Lie, PhD
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 11 top young scientists
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators
3. 2009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
4. BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award
5. DNA discovery opens new door to develop tools, therapies for hereditary cancers
6. Fish oil may reduce risk of breast cancer
7. New retrieval method makes studying cancer proteins easier
8. UNC team finds new target for treatment of advanced prostate cancer
9. Multicolor quantum dots aid in cancer biopsy diagnosis
10. Mystery unraveled: How asbestos causes cancer
11. Immune system important in fight against stomach cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... Mar. 20, 2015 Research and Markets ... of the "India Sensors Market Forecast and ... The sensor market is projected to grow ... Consumer electronics, automotive, industrial and healthcare sectors ... the country. In addition, adoption of MEMS technology ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... National Heart, Lung and Blood Institute, one of the ... the Johns Hopkins University School of Medicine each approximately ... two Programs of Excellence in Glycosciences. Gerald Hart, Ph.D., ... of pharmacology and molecular sciences, will lead these independent ...
... every day could help control Type 2 diabetes and ... Michael,s Hospital and the University of Toronto. In ... Care , a team of researchers led by Dr. ... St. Michael,s Hospital Risk Factor Modification Centre) reports that ...
... 07/07/11, Clearwater Beach, FL. Research to be ... for the Study of Ingestive Behavior (SSIB), the foremost ... drinking behavior, suggests that people can become dependent on ... of consumption, similar to the behaviors we observe in ...
Cached Biology News:Johns Hopkins researchers awarded $32 million 2A 'nutty' solution to type 2 diabetes management 2Evidence for 'food addiction' in humans 2
(Date:4/23/2015)... 2015 Glemser Technologies ... EMC® Enterprise Content Division (ECD) Certified Solution Partner ... Documentum® for Life Sciences Solution Suite . The ... capabilities to provide life sciences companies of all ... The EMC Documentum Solution Suite offers four modules: ...
(Date:4/23/2015)... HOUSTON , April 23, 2015  Metanome, ... today announced the company has changed its name ... reflect Diversigen,s positioning as the single commercial source ... need to capitalize on the diverse opportunities of ... types that Diversigen accepts – including those that ...
(Date:4/23/2015)... NY , April 23, 2015 /PRNewswire/ - Crystal ... an Executive Informational Overview ® (EIO) on Aeterna ... 52-page report is available on Crystal Research Associates, website ... on Aeterna Zentaris, website at www.aezsinc.com . ... into a specialty biopharmaceutical company in oncology, endocrinology, and ...
(Date:4/23/2015)... 2015 Delpor, Inc. (Delpor), a biotechnology ... United States Patent and Trademark Office has issued 2 ... technology. US Pat. No. 8,986,727 was issued on ... delivery device for the sustained release of therapeutic ... the sustained (zero-order) release of large and small molecules ...
Breaking Biology Technology:Glemser Earns Accreditation for Life Sciences Solution Suite 2Metanome Announces Corporate Name Change to Diversigen 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 3Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3
... HOPKINTON, Mass. , June 25 Caliper Life Sciences, ... services for drug discovery and life sciences research, hosted its 2010 ... and 10. This thought-leadership conference is focused on sharing knowledge, ... leading to the next generation of breakthrough diagnostics and therapies. , ...
... sequencing and analysis of the human body louse genome, ... Proceedings of the National Academy of Sciences (PNAS), ... disease-vector insect. The project involved more than 70 international ... of Geneva Medical School and the SIB Swiss Institute ...
... of an electron to exist in two places at once ... silicon - for the first time. The research findings - ... the University of Surrey, UCL (University College) London, Heriot-Watt University ... Utrecht - marks a significant step towards the making of ...
Cached Biology Technology:Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 2Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 3Sequencing of the human body louse genome 2'Quantum computer' a stage closer with silicon breakthrough, reports Nature journal 2
... Antibody - Red, 20X ... antibody at 20X concentration for use ... assays. Quality Assurance ... FarRed fluorescence polarization assays. ...
Kinase Buffer can be used to assay protein kinase activity...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: